Dr. Joshua Makower serves as a Consulting Associate Professor of Medicine at Stanford University Medical School and is a consultant and real world mentor of the Stanford Byers Center for Biodesign, and Co-Founder of the Biodesign Innovation Program at Stanford. He is also the Founder and Chief Executive Officer of ExploraMed, a medical device incubator based on the west coast and is also a Venture Partner with New Enterprise Associates. Dr. Makower will become director of the Stanford Byers Center for Biodesign on August 1st, 2021.
Prior to this, he was Founder, Chairman and Chief Technical Officer of TransVascular, Inc. a company focused on the development of a completely catheter-based coronary bypass technology, which was acquired by Medtronic, Inc. in 2003, and Founder and Chairman of EndoMatrix, Inc., a company focused on the development of a novel therapy for incontinence and GI Reflux, which was acquired by C.R. Bard in 1997. Up until 1995, Dr. Makower was Founder and Manager of Pfizers Strategic Innovation Group, a group chartered to create new medical device technologies and businesses for Pfizers medical devices businesses.
Dr. Makower holds over four dozen patents for various medical devices in the fields of Cardiology, ENT, Orthopedics, General Surgery, Drug Delivery and Urology. Dr. Makower holds a Masters of Business Administration degree from Columbia University, a Doctor of Medicine degree from the New York University School of Medicine, and a Bachelor of Science degree in Mechanical Engineering from the Massachusetts Institute of Technology. Dr. Makower also serves as Chairman of the Board for Acclarent, Inc., NeoTract, Inc., Vibrynt, Inc., Moximed, Inc, and on the Board of Directors for Intrinsic Therapeutics, Inc. - a venture backed private company developing innovative spinal therapies.